East Windsor, NJ, United States of America

Kalyanam Nagabhushanam

This inventor holds 97 USPTO granted patents and 40 published patent applications, plus 41 CIPO patents and 39 EPO patents, primarily in Therapeutic Compositions (CPC class A61K35-742). Top assignees: Sami Labs Limited, Sami-Sabinsa Group Limited, Sabinsa Corporation. Active years: 2004-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kalyanam Nagabhushanam. Retrieved from https://idiyas.com/inventor/kalyanam-nagabhushanam

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 97 (Patent Applications = 40)

% Patents Active = 87.6

CIPO Patents = 41 (Patent Applications = 24)

EPO Patents = 39 (Patent Applications = 54)

Average Co-Inventor Count = 3.8

ph-index = 5

Forward Citations = 75(Granted Patents)

Forward Citations (Not Self Cited) = 48(Dec 10, 2025)

Inventors with similar research interests:

Location History:

North Brunswick, NJ (US) (2004 - 2008)
Piscataway, NJ (US) (2007 - 2015)
East Windsor, NJ (US) (2012 - 2024)

Company Filing History:

Sami-Sabinsa Group Limited

5. 8 out of 834,601

Other

patents

where one patent can have more than one assignee

Years Active: 2004-2025

Loading Chart...

Areas of Expertise:

Neurotoxicity Management

Metabolic Syndrome

Chronic Diseases

Polycystic Ovary Syndrome

Pulmonary Fibrosis

Weight Loss

Lactose Intolerance

Beta Secretase Inhibition

Anti-Aging

Hyperglycemia

Immune Function Modulation

97 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12465585 - Compositions for the management of seizure induced neurotoxicity (2025-11-11),

2. 12257274 - Fructophilic lactic acid producing bacteria (2025-03-25),

3. 12240808 - Process for the synthesis of calebin-a and its intermediates (2025-03-04),

4. 12233032 - Compositions for management of polycystic ovary syndrome (2025-02-25),

5. 12053500 - Compositions for management of acute nephrotoxicity (2024-08-06),

6. 12022786 - Method of isolating secondary metabolites from cambium derived callus cultures (2024-07-02),

7. 11957728 - Compositions for targeting receptor for advanced glycation end-products (RAGE) in a chronic inflammatory condition (2024-04-16),

8. 11925671 - Process and compositions for enhancing energy expenditure (2024-03-12),

9. 11925606 - Compositions for managing chronic obstructive pulmonary disease (2024-03-12),

10. 11865203 - Skin care applications of extracellular metabolites from Bacillus coagulans (2024-01-09),

11. 11744807 - Therapeutic compositions and methods for pulmonary fibrosis (2023-09-05),

12. 11707438 - Curcuminoid composition for therapeutic management of metabolic syndrome (2023-07-25),

13. 11491119 - Curcuminoid composition and its therapeutic potential in managing lung fibrosis (2022-11-08),

14. 11458117 - Compositions and methods for beta secretase inhibition (2022-10-04),

15. 11419906 - Method and composition for therapeutic management of gluten intolerance (2022-08-23),

Title: The Innovative Mind of Kalyanam Nagabhushanam

Introduction:

Kalyanam Nagabhushanam, a distinguished inventor hailing from East Windsor, NJ (US), is renowned for his groundbreaking contributions to the field of technology and innovation.

Latest Patents:

Nagabhushanam's latest patents showcase his expertise in developing cutting-edge solutions for various industries, including telecommunications, renewable energy, and healthcare.

Career Highlights:

With a career spanning over two decades, Nagabhushanam has held key roles in leading research institutions and technology companies, where he has spearheaded numerous projects that have revolutionized the way we approach complex challenges.

Collaborations:

Throughout his career, Nagabhushanam has collaborated with top-tier universities, multinational corporations, and research institutions to drive forward innovation and bring his visionary ideas to life.

Conclusion:

In conclusion, Kalyanam Nagabhushanam stands as a true pioneer in the world of inventions, with a remarkable track record of transforming bold ideas into tangible solutions that have a lasting impact on society.

Profile summary based on public USPTO records.